Human cathepsin X -: A novel cysteine protease with unique specificity

被引：0
|
作者：
Ménard, R [1 ]
Nägler, DK [1 ]
Zhang, RL [1 ]
Tam, W [1 ]
Sulea, T [1 ]
Purisima, EO [1 ]
机构：
[1] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
来源：
CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2 | 2000年 / 477卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：317 / 322
页数：6
相关论文
共 50 条
  • [31] Role of the cysteine protease cathepsin S in neuropathic hyperalgesia
    Barclay, Jane
    Clark, Anna K.
    Ganp, Pam
    Gentry, Clive
    Patel, Sadhana
    Wotherspoon, Glen
    Buxton, Frank
    Song, Chuanzheng
    Ullah, Jakir
    Winter, Janet
    Fox, Alyson
    Bevan, Stuart
    Malcangio, Marzia
    PAIN, 2007, 130 (03) : 225 - 234
  • [32] In search of selective inhibitors of cysteine protease, cathepsin K
    Wieczerzak, E
    Drabik, P
    Abrahamson, M
    Grubb, A
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2005, 11 (03) : 203 - 209
  • [33] Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L
    Bocock, JP
    Edgell, CJS
    Marr, HS
    Erickson, AH
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (19): : 4008 - 4015
  • [34] Carboxy-monopeptidase substrate specificity of human cathepsin X
    Devanathan, G
    Turnbull, JL
    Ziomek, E
    Purisima, EO
    Ménard, R
    Sulea, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (02) : 445 - 452
  • [35] Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
    Marquis, RW
    Ru, Y
    Yamashita, DS
    Oh, HJ
    Yen, J
    Thompson, SK
    Carr, TJ
    Levy, MA
    Tomaszek, TA
    Ijames, CF
    Smith, WW
    Zhao, BG
    Janson, CA
    Abdel-Meguid, SS
    D'Alessio, KJ
    McQueney, MS
    Veber, DF
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) : 581 - 588
  • [36] Cyclic ketone inhibitors of the cysteine protease cathepsin K
    Marquis, RW
    Ru, Y
    Zeng, J
    Trout, REL
    LoCastro, SM
    Gribble, AD
    Witherington, J
    Fenwick, AE
    Garnier, B
    Tomaszek, T
    Tew, D
    Hemling, ME
    Quinn, CJ
    Smith, WW
    Zhao, BG
    McQueney, MS
    Janson, CA
    D'Alessio, K
    Veber, DF
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) : 725 - 736
  • [37] Inhibition of the cysteine protease cathepsin K (EC 3.4.22.38)
    Marquis, RW
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39, 2004, 39 : 79 - 98
  • [38] Cathepsin L: a matrix degrading cysteine protease in osteoarthritis
    Clements, K. M.
    Palmer, A.
    Jones, E.
    Tart, J.
    Newham, P.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2009, 90 (01) : A70 - A71
  • [39] The emerging relevance of the cysteine protease cathepsin S in disease
    Small D.M.
    Burden R.E.
    Scott C.J.
    Clinical Reviews in Bone and Mineral Metabolism, 2011, 9 (2): : 122 - 132
  • [40] THE CYSTEINE PROTEASE CATHEPSIN B IS A KEY DRUG TARGET AND CYSTEINE PROTEASE INHIBITORS ARE POTENTIAL THERAPEUTICS FOR TBI
    Hook, G. R.
    Yu, J.
    Sipes, N.
    Pierschbacher, M. D.
    Hook, V
    Kindy, M. S.
    JOURNAL OF NEUROTRAUMA, 2014, 31 (12) : A88 - A88
12345